Are Caregiver-Reported Outcomes an Important Component to the Treatment Experience of Patients With CRC?
Researchers sought to determine the effect of caregivers’ emotions and distress on outcomes for patients with colorectal cancer.
Colorectal Cancer
Erbitux Plus Encorafenib Approved for BRAF V600E Mutation-Positive Metastatic Colorectal Cancer
The approval is supported by data from the phase 3 BEACON CRC trial in adults with BRAF V600E mutation-positive metastatic colorectal cancer with disease progression.
Study Compares Prevalence, Severity of Peripheral Neuropathy in CRC Survivors and Patients With Diabetes
A comparison of data from 2 studies on peripheral neuropathy found that CRC survivors would benefit from education related to recognizing early symptoms.
Age Shouldn’t Dictate Aggressiveness of Treatment in Colorectal Cancer, Researchers Say
The study showed no significant differences in outcomes by age.
Liver Metastases Linked to Immunotherapy Resistance in Microsatellite Stable Colorectal Cancer
Patients with liver metastases did not respond to checkpoint inhibitors.
Cetuximab Plus Avelumab as Rechallenge Therapy for RAS WT Metastatic Colorectal Cancer
The overall response rate was 7.8%, and the disease control rate was 65%.
‘Harmful’ Articles on Cancer Treatment Get More Engagement on Social Media
About 31% of the articles analyzed contained information classified as harmful.
Long-Term Aspirin Use Before Diagnosis May Reduce Risk of Death From Colorectal Cancer
Aspirin may prevent distant metastases, according to researchers.
No Survival Benefit With Primary Tumor Resection in Stage IV Colorectal Cancer
Phase 3 results refute findings from retrospective studies.
Dose Capping May Explain Reduced Survival in Patients With Colorectal Cancer and High BMI
The results suggest a link, but more research is needed.
- Loading...
Loading...
Next post in Gastrointestinal Cancer
Loading... 
Loading...